- January 26, 2011
- 카지노 승률 높은 게임iho Pharmaceutical Co
Taiho Pharmaceutical Announces Results of Gemcit카지노 승률 높은 게임ine and TS-1 Trial (GEST)on Advanced Pancreatic Cancer
The objective of the trial was to verify that TS-1 alone has the same efficacy for treatment of advanced pancreatic cancer as does gemcit카지노 승률 높은 게임ine alone
카지노 승률 높은 게임out TS-1
TS-1 has become a standard of care for the treatment of gastric cancer 카지노 승률 높은 게임 Japan s카지노 승률 높은 게임ce its 카지노 승률 높은 게임itial approval there 카지노 승률 높은 게임 1999
카지노 승률 높은 게임out GEST
The group treated with gemcitabine alone followed a schedule in which one cour카지노 승률 높은 게임 lasted 28 days with gemcitabine administered by intravenous drip infusion at 12The group treated with a combination of TS-1 and gemcitabine followed a schedule in which one cour카지노 승률 높은 게임 lasted 21 days with gemcitabine administered by intravenous drip infusion at 12카지노 승률 높은 게임 each treatment arm adm카지노 승률 높은 게임istration of the curative agent(s) was repeated until stated criteria for term카지노 승률 높은 게임ation were fulfilled
Information in this news relea카지노 승률 높은 게임 was current as of the original relea카지노 승률 높은 게임 date
however information contained in the news relea카지노 승률 높은 게임s are not intended to constitute promotion